Federation of European Biochemical Societies. Published by Elsevier B.V.
Doi
Abstract
AbstractDesign and switch of catalytic activity in enzymology remains a subject of intense investigation. Here, we employ a DNAzyme–RNAzyme combination strategy for construction of a 10–23 deoxyribozyme-hammerhead ribozyme combination that targets different sites of the β-lactamase mRNA. The 10–23 deoxyribozyme-hammerhead ribozyme combination gene was cloned into phagemid vector pBlue-scriptIIKS (+). In vitro the single-strand recombinant phagemid vector containing the combination sequence exhibited 10–23 deoxyribozyme activity, and the linear transcript displayed hammerhead ribozyme activity. In bacteria, the 10–23 deoxyribozyme-hammerhead ribozyme combination inhibited the β-lactamase expression and repressed the growth of drug-resistant bacteria. Thus, we created a DNAzyme–RNAzyme combination strategy that provides a useful approach to design and switch of catalytic activities for nucleic acid enzymes
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.